[1]
|
Bae, K.T., Zhou, W., Shen, C., et al. (2019) Growth Pattern of Kidney Cyst Number and Volume in Autosomal Domi-nant Polycystic Kidney Disease. Clinical Journal of the American Society of Nephrology, 14, 823-833.
https://doi.org/10.2215/CJN.10360818
|
[2]
|
Grantham, J.J., Mulamalla, S. and Swenson-Fields, K.I. (2011) Why Kidneys Fail in Autosomal Dominant Polycystic Kidney Disease. Nature Reviews Nephrology, 7, 556-566. https://doi.org/10.1038/nrneph.2011.109
|
[3]
|
Edwards, M.E., Chebib, F T, Irazabal M V, et al. (2018) Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease. Clinical Journal of the American Society of Nephrology, 13, 1153-1161.
https://doi.org/10.2215/CJN.01520218
|
[4]
|
Rysz, J., Gluba-Brzózka, A., Franczyk, B., et al. (2016) Combination Drug versus Monotherapy for the Treatment of Autosomal Dominant Polycystic Kidney Disease. Expert Opinion on Pharmacotherapy, 17, 2049-2056.
https://doi.org/10.1080/14656566.2016.1232394
|
[5]
|
Tyson, M.D. and Humphreys, M.R. (2014) Urological Ap-plications of Natural Orifice Transluminal Endoscopic Surgery (NOTES). Nature Reviews Urology, 11, 324-332. https://doi.org/10.1038/nrurol.2014.96
|
[6]
|
Walz, G., Budde, K., Mannaa, M., et al. (2010) Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease. The New England Journal of Medicine, 363, 830-840. https://doi.org/10.1056/NEJMoa1003491
|
[7]
|
Abbott, K.C. and Agodoa, L.Y. (2002) Polycystic Kidney Disease at End-Stage Renal Disease in the United States: Patient Characteristics and Survival. Clinical Nephrology, 57, 208-214. https://doi.org/10.5414/CNP57208
|
[8]
|
Jung, Y., Irazabal, M.V., Chebib, F.T., et al. (2015) Volume Regression of Native Polycystic Kidneys after Renal Transplantation. Nephrology Dialysis Transplantation, 31, 73-79. https://doi.org/10.1093/ndt/gfv227
|
[9]
|
Lotan, Y., Daudon, M., Bruyère, F., et al. (2013) Impact of Fluid Intake in the Prevention of Urinary System Diseases: A Brief Review. Current Opinion in Nephrology & Hypertension, 22, S1-S10.
https://doi.org/10.1097/MNH.0b013e328360a268
|
[10]
|
Casteleijn, N.F., Messchendorp, A.L., Bae, K.T., et al. (2016) Polyuria Due to Vasopressin V2 Receptor Antagonism Is Not Associated with Increased Ureter Diameter in ADPKD Patients. Clinical & Experimental Nephrology, 21, 375-382. https://doi.org/10.1007/s10157-016-1297-1
|
[11]
|
Carlsson, S., Wiklund, N.P., Engstrand, L., et al. (2001) Effects of pH, Nitrite, and Ascorbic Acid on Nonenzymatic Nitric Oxide Generation and Bacterial Growth in Urine. Nitric Oxide, 5, 580-586.
https://doi.org/10.1006/niox.2001.0371
|
[12]
|
Flo, T.H., Smith, K.D., Sato, S., et al. (2004) Lipocalin 2 Mediates an Innate Immune Response to Bacterial Infection by Sequestrating Iron. Nature, 432, 917-921. https://doi.org/10.1038/nature03104
|
[13]
|
Casteleijn, N.F., Visser, F.W., Drenth, J.P.H., et al. (2014) A Stepwise Approach for Effective Management of Chronic Pain in Autosomal-Dominant Polycystic Kidney Disease. Nephrology Dialysis Transplantation, 29, iv142-iv153.
https://doi.org/10.1093/ndt/gfu073
|
[14]
|
Torres, V.E., Chapman, A.B., De Vuyst, O., et al. (2012) Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease. New England Journal of Medicine, 367, 2407-2418. https://doi.org/10.1056/NEJMoa1205511
|
[15]
|
Santoro, D., Satta, E., Messina, S., et al. (2013) Pain in End-Stage Renal Disease: A Frequent and Neglected Clinical Problem. Clinical Nephrology, 79, 2-11. https://doi.org/10.5414/CNX77S104
|
[16]
|
Allan, L., Hays, H., Jensen, N.H., et al. (2001) Randomised Crossover Trial of Transdermal Fentanyl and Sustained Release Oral Morphine for Treating Chronic Non-Cancer Pain. British Medical Journal, 322, Article No. 1154.
https://doi.org/10.1136/bmj.322.7295.1154
|
[17]
|
Tellman, M.W., et al. (2015) Management of Pain in Autosomal Dominant Polycystic Kidney Disease and Anatomy of Renal Innervation. Journal of Urology, 193, 1470-1478. https://doi.org/10.1016/j.juro.2014.10.124
|
[18]
|
Hall, H. and Leach, A. (1999) Paravertebral Block in the Man-agement of Liver Capsule Pain after Blunt Trauma. British Journal of Anaesthesia, 83, 819-821. https://doi.org/10.1093/bja/83.5.819
|
[19]
|
Peces, R., et al. (2012) Medical Therapy with Tranexamic Acid in Au-tosomal Dominant Polycystic Kidney Disease Patients with Severe Haematuria. Nefrología: Publicación Oficial De La Sociedad Espaola Nefrologia, 32, 160-165.
|
[20]
|
Suwabe, T., Ubara, Y., Sumida, K., et al. (2012) Clinical Features of Cyst Infection and Hemorrhage in ADPKD: New Diagnostic Criteria. Clinical and Experimental Nephrology, 16, 892-902. https://doi.org/10.1007/s10157-012-0650-2
|
[21]
|
Qu, M.L., Ramirez-Giraldo, J.C., Leng, S., et al. (2011) Dual-Energy Dual-Source CT with Additional Spectral Filtration Can Improve the Differentiation of Non-Uric Acid Renal Stones: An Ex Vivo Phantom Study. American Journal of Roentgenology, 196, 1279-1287. https://doi.org/10.2214/AJR.10.5041
|
[22]
|
Liu, Y., Li, Y., Li, N., et al. (2012) Flexible Ureteroscopy and Holmium Laser Lithotripsy for Treatment of Upper Urinary Tract Calculi in Patients with Autosomal Dominant Polycystic Kidney Disease. Urological Research, 40, 87-91. https://doi.org/10.1007/s00240-011-0390-x
|
[23]
|
Umbreit, E.C., Childs, M.A., Patterson, D.E., et al. (2010) Percutaneous Nephrolithotomy for Large or Multiple Upper Tract Calculi and Autosomal Dominant Polycystic Kidney Disease. Journal of Urology, 183, 183-187.
https://doi.org/10.1016/j.juro.2009.08.141
|
[24]
|
Krishnan, N. and Perazella, M.A. (2017) The Role of PET Scan-ning in the Evaluation of Patients with Kidney Disease. Advances in Chronic Kidney Disease, 24, 154-161. https://doi.org/10.1053/j.ackd.2017.01.002
|
[25]
|
Suwabe, T., Araoka, H., Ubara, Y., et al. (2015) Cyst Infection in Autosomal Dominant Polycystic Kidney Disease: Causative Microorganisms and Susceptibility to Lipid-Soluble Antibiotics. European Journal of Clinical Microbiology & Infectious Diseases, 34, 1369-1379. https://doi.org/10.1007/s10096-015-2361-6
|
[26]
|
Harris, P.C. and Torres, V.E. (2006) Polycystic Kidney Disease, Autosomal Dominant. Springer, Berlin.
|
[27]
|
Sallée, M., et al. (2009) Cyst Infections in Patients with Autosomal Dominant Polycystic Kidney Disease. Clinical Journal of the American Society of Nephrology, 4, 1183-1189. https://doi.org/10.2215/CJN.01870309
|
[28]
|
Hogan, M.C., Abebe, K., Torres, V.E., (2015) Liver Involvement in Early Autosomal-Dominant Polycystic Kidney Disease. Clinical Gastroenterology and Hepatology, 13, 155-164.E6. https://doi.org/10.1016/j.cgh.2014.07.051
|
[29]
|
Chauveau, D., Fakhouri, F. and Grünfeld, J.P. (2000) Liver In-volvement in Autosomal-Dominant Polycystic Kidney Disease: Therapeutic Dilemma. Journal of the American Society of Nephrology, 11, 1767-1775.
https://doi.org/10.1681/ASN.V1191767
|
[30]
|
Pei, Y. and Watnick, T. (2010) Autosomal Dominant Polycystic Kidney Disease. Advances in Chronic Kidney Disease, 17, 115-117. https://doi.org/10.1053/j.ackd.2009.12.002
|
[31]
|
Drenth, J., Chrispijn, M., Nagorney, D.M., et al. (2010) Medical and Surgical Treatment Options for Polycystic Liver Disease. Hepatology, 52, 2223-2230. https://doi.org/10.1002/hep.24036
|
[32]
|
Hogan, M.C., Masyuk, T., Bergstralh, E., et al. (2015) Efficacy of 4 Years of Octreotide Long-Acting Release Therapy in Patients with Severe Polycystic Liver Disease. Mayo Clinic Proceedings, 90, 1030-1037.
https://doi.org/10.1016/j.mayocp.2015.05.011
|
[33]
|
Schrier, R.W., Johnson, A.M., Mcfann, K., et al. (2003) The Role of Parental Hypertension in the Frequency and Age of Diagnosis of Hypertension in Offspring with Autoso-mal-Dominant Polycystic Kidney Disease. Kidney International, 64, 1792-1799. https://doi.org/10.1046/j.1523-1755.2003.00264.x
|
[34]
|
Ritchie, L.D., Campbell, N.C. and Murchie, P. (2011) New NICE Guidelines for Hypertension. British Medical Journal, 343, d5644. https://doi.org/10.1136/bmj.d5644
|
[35]
|
Chapman, A.B., Guay-Woodford, L.M., Grantham, J.J., et al. (2003) Renal Structure in Early Autosomal-Dominant Polycystic Kidney Disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) Cohort. Kidney International, 64, 1035-1045. https://doi.org/10.1046/j.1523-1755.2003.00185.x
|
[36]
|
Lumiaho, A., Pihlajamäki, J., Hartikainen, J., et al. (2003) Insulin Resistance Is Related to Left Ventricular Hypertrophy in Patients with Polycystic Kidney Disease Type 1. American Journal of Kidney Diseases, 41, 1219-1224.
https://doi.org/10.1016/S0272-6386(03)00354-8
|
[37]
|
Ecder, T., Edelstein, C.L., Fick-Brosnahan, G.M., et al. (2000) Progress in Blood Pressure Control in Autosomal Dominant Polycystic Kidney Disease. American Journal of Kidney Diseases, 36, 266-271.
https://doi.org/10.1053/ajkd.2000.8970
|
[38]
|
Raoul, Z., Roudolf, P., Birgit, S., et al. (2008) Renal and Cardiac Effects of Antihypertensive Treatment with Ramipril vs Metoprolol in Autosomal Dominant Polycystic Kidney Disease. Nephrology Dialysis Transplantation, 23, 431-433.
https://doi.org/10.1093/ndt/gfm865
|
[39]
|
Helal, I., Al-Rowaie, F., Abderrahim, E., et al. (2017) Update on Path-ogenesis, Management, and Treatment of Hypertension in Autosomal Dominant Polycystic Kidney Disease. Saudi Journal of Kidney Diseases and Transplantation, 28, 253-260. https://doi.org/10.4103/1319-2442.202774
|
[40]
|
Pirson, Y., Chauveau, D. and Torres, V. (2002) Management of Cerebral Aneurysms in Autosomal Dominant Polycystic Kidney Disease. Journal of the American Society of Nephrology, 13, 269-276.
https://doi.org/10.1681/ASN.V131269
|
[41]
|
Belz, M.M., Hughes, R.L., Kaehny, W.D., et al. (2001) Familial Clustering of Ruptured Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease. American Journal of Kidney Diseases, 38, 770-776.
https://doi.org/10.1053/ajkd.2001.27694
|
[42]
|
Albrecht, W., Rinkel, G., Wermer, M., et al. (2006) Yield of Short-Term Follow-Up CT/MR Angiography for Small Aneurysms Detected at Screening. Stroke, 37, 414-418. https://doi.org/10.1161/01.STR.0000199077.06390.35
|
[43]
|
Gieteling, E.W. and Rinkel, G. (2003) Characteristics of Intracranial Aneurysms and Subarachnoid Haemorrhage in Patients with Polycystic Kidney Disease. Journal of Neurology, 250, 418-423.
https://doi.org/10.1007/s00415-003-0997-0
|
[44]
|
Chebib, F.T. and Torres, V.E. (2016) Autosomal Dominant Polycystic Kidney Disease: Core Curriculum 2016. American Journal of Kidney Diseases, 67, 792-810. https://doi.org/10.1053/j.ajkd.2015.07.037
|